2412496-23-0
2412496-23-0 structure
- Name: Nezulcitinib
- Chemical Name: Nezulcitinib
- CAS Number: 2412496-23-0
- Molecular Formula: C30H37N7O2
- Molecular Weight: 527.66
- Catalog: Signaling Pathways Epigenetics JAK
- Create Date: 2021-12-20 12:12:41
- Modify Date: 2025-09-03 13:09:56
-
Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor. Nezulcitinib can be used for the research of COVID-19 associated acute lung injury and impaired oxygenation[1][2].
| Name | Nezulcitinib |
|---|
| Description | Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor. Nezulcitinib can be used for the research of COVID-19 associated acute lung injury and impaired oxygenation[1][2]. |
|---|---|
| Related Catalog | |
| Target |
JAK |
| In Vitro | Nezulcitinib (TD-0903) is an inhaled and lung-selective pan-Janus kinase (JAK) inhibitor[1][2]. |
| References |
[1]. Theravance's nezulcitinib fails to meet Phase II goals in Covid-19 |
| Molecular Formula | C30H37N7O2 |
|---|---|
| Molecular Weight | 527.66 |